EMA AI Tool Qualification: How the AIM-NASH App...

By Rene Pretorius

May 19, 2025

The European Medicines Agency (EMA) has issued its first Qualification Opinion (QO) for an
EFPIA Advocates for Stronger Life Sciences in EU Multiannual Financial Framework
FDA AI Drug Approval
AI Pediatric Sarcoma Diagnosis: Improving Speed and Accuracy in Cancer Classi...
AI Moral Decision-Making: Navigating the Complexities of Kidney Allocation De...
AI Kidney Disease Detection: Transforming Eye Screenings for Diabetic Patients
Hypertension Detection: HTN-AI Model for Cardiovascular Risk Stratification
Advances in Cervical Cancer Classification: Comparing Deep Learning Models fo...
AI Decision Support in Aortic Stenosis Detection
Cultural Challenges Hindering AI in Maternal Healthcare in Africa
AI Tool Predicts Type 2 Diabetes Risk via ECG Up to 10 Years Early
Diabetes Diagnosis through Retinal Imaging and Deep Learning
NICE’s Position on AI in Evidence Generation